ArticleOncotarget2015

Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway.

Annalisa Conti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.